GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » DVx Inc (TSE:3079) » Definitions » Cyclically Adjusted Revenue per Share

DVx (TSE:3079) Cyclically Adjusted Revenue per Share : 円3,899.33 (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is DVx Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

DVx's adjusted revenue per share for the three months ended in Dec. 2023 was 円1,111.619. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is 円3,899.33 for the trailing ten years ended in Dec. 2023.

During the past 12 months, DVx's average Cyclically Adjusted Revenue Growth Rate was 8.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 9.20% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 9.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of DVx was 9.60% per year. The lowest was 9.20% per year. And the median was 9.20% per year.

As of today (2024-06-08), DVx's current stock price is 円1004.00. DVx's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was 円3,899.33. DVx's Cyclically Adjusted PS Ratio of today is 0.26.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of DVx was 0.61. The lowest was 0.22. And the median was 0.32.


DVx Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for DVx's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DVx Cyclically Adjusted Revenue per Share Chart

DVx Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,533.88 2,827.36 3,045.94 3,331.76 3,677.27

DVx Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,608.96 3,677.27 3,755.65 3,833.00 3,899.33

Competitive Comparison of DVx's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, DVx's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DVx's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, DVx's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where DVx's Cyclically Adjusted PS Ratio falls into.



DVx Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, DVx's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=1111.619/106.8000*106.8000
=1,111.619

Current CPI (Dec. 2023) = 106.8000.

DVx Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 622.796 95.700 695.033
201406 628.324 98.000 684.745
201409 631.143 98.500 684.326
201412 632.278 97.900 689.758
201503 648.410 97.900 707.356
201506 650.694 98.400 706.241
201509 657.461 98.500 712.861
201512 694.738 98.100 756.351
201603 778.817 97.900 849.619
201606 755.032 98.100 821.992
201609 764.060 98.000 832.669
201612 788.816 98.400 856.154
201703 819.207 98.100 891.858
201706 862.166 98.500 934.816
201709 813.116 98.800 878.955
201712 874.247 99.400 939.332
201803 844.614 99.200 909.322
201806 887.863 99.200 955.885
201809 876.133 99.900 936.647
201812 945.665 99.700 1,013.009
201903 959.351 99.700 1,027.670
201906 1,003.500 99.800 1,073.886
201909 1,067.461 100.100 1,138.909
201912 1,107.723 100.500 1,177.162
202003 1,084.583 100.300 1,154.870
202006 839.106 99.900 897.062
202009 1,038.137 99.900 1,109.840
202012 1,081.521 99.300 1,163.207
202103 1,017.456 99.900 1,087.731
202106 1,050.032 99.500 1,127.070
202109 1,080.621 100.100 1,152.950
202112 1,153.857 100.100 1,231.088
202203 1,108.368 101.100 1,170.858
202206 1,134.465 101.800 1,190.185
202209 1,140.345 103.100 1,181.269
202212 1,144.969 104.100 1,174.666
202303 1,147.036 104.400 1,173.405
202306 1,114.250 105.200 1,131.197
202309 1,055.810 106.200 1,061.775
202312 1,111.619 106.800 1,111.619

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


DVx  (TSE:3079) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

DVx's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1004.00/3899.33
=0.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of DVx was 0.61. The lowest was 0.22. And the median was 0.32.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


DVx Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of DVx's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


DVx (TSE:3079) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Mejiro Nakano Building, 5th Floor, 2-17-22 Takada, Toshima-ku, Tokyo, JPN, 171-0033
DVx Inc is engaged in manufacture, sale, repair, and leasing of medical equipment and related peripheral equipment, research and development of medical equipment, provide in house and out of service consulting services and services for medical and medical devices, and providing medical publication and market research.

DVx (TSE:3079) Headlines

No Headlines